Clinical Trial Update: Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating intermittent androgen deprivation therapy for prostate cancer in the era of AR pathway inhibitors; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING